Literature DB >> 9599720

Immune cell functions in industrial workers after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: dissociation of antigen-specific T-cell responses in cultures of diluted whole blood and of isolated peripheral blood mononuclear cells.

M Ernst1, D Flesch-Janys, I Morgenstern, A Manz.   

Abstract

A comparative analysis was performed of the phenotype and function of peripheral blood leukocytes of two age-matched cohorts of industrial workers in chemical plants, one of which was exposed occupationally to high concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Median actual TCDD burdens were 116 ng/kg and 4 ng/kg, respectively. The phenotype analysis of peripheral blood mononuclear cells (PBMC) revealed no significant differences in the proportions of CD3, CD4, or CD8+ T lymphocytes, of CD16+ natural killer cells, and of CD19+ B lymphocytes. However, in PBMC of the TCDD-exposed workers; the proportion of CD8+ memory T cells (CD45R0+) was significantly higher, and that of lymphocytes with naive phenotype (CD45RA+) was significantly lower than in PBMC of the control group. Polyclonal and antigen-specific T-cell activation was assessed in parallel in isolated PBMC as well as in diluted whole blood cultures. In both culture systems the polyclonally stimulated cytokine release did not differ significantly between the two cohorts; however, we found a significantly reduced interferon gamma release in diluted whole blood cultures but not in isolated PBMC cultures of the TCDD-exposed cohort when we performed an antigen-specific T-cell stimulation with tetanus-toxoid. Therefore, we propose that exposure of individuals to high doses of TCDD can partially impair in the "blood milieu" those T-cell/monocyte interactions that are essential for antigen-specific T-cell responses, whereas isolated PBMC of the same donors appear functionally less affected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9599720      PMCID: PMC1533402          DOI: 10.1289/ehp.98106701

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  11 in total

1.  An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells.

Authors:  E Grage-Griebenow; J Baran; H Loppnow; M Los; M Ernst; H D Flad; J Pryjma
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

2.  2,3,7,8-TCDD induces cytochrome P450 enzyme activity but not proliferation or phenotypical changes in human peripheral blood lymphocytes.

Authors:  D S Lang; S Becker; R B Devlin; H S Koren
Journal:  Toxicol Lett       Date:  1996-11       Impact factor: 4.372

3.  Immunological abnormalities 17 years after accidental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  A M Jennings; G Wild; J D Ward; A M Ward
Journal:  Br J Ind Med       Date:  1988-10

4.  Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8,-tetrachlorodibenzo-p-dioxin.

Authors:  S A Kraemer; K A Arthur; M S Denison; W L Smith; D L DeWitt
Journal:  Arch Biochem Biophys       Date:  1996-06-15       Impact factor: 4.013

Review 5.  Effects of small doses of dioxins on the immune system of marmosets and rats.

Authors:  R Neubert; R Stahlmann; M Korte; H van Loveren; J G Vos; G Golor; J R Webb; H Helge; D Neubert
Journal:  Ann N Y Acad Sci       Date:  1993-06-23       Impact factor: 5.691

6.  Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity.

Authors:  E Grage-Griebenow; D Lorenzen; R Fetting; H D Flad; M Ernst
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

Review 7.  A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update.

Authors:  M P Holsapple; N K Snyder; S C Wood; D L Morris
Journal:  Toxicology       Date:  1991       Impact factor: 4.221

8.  Chlorinated dibenzo-p-dioxins and dibenzofurans and the human immune system. 2. In vitro proliferation of lymphocytes from workers with quantified moderately-increased body burdens.

Authors:  R Neubert; L Maskow; I Delgado; H Helge; D Neubert
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

9.  Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  T Tonn; C Esser; E M Schneider; W Steinmann-Steiner-Haldenstätt; E Gleichmann
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

Review 10.  Immunological effects of chlorinated dibenzo-p-dioxins.

Authors:  N I Kerkvliet
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

View more
  4 in total

1.  Dioxins and furans: epidemiologic assessment of cancer risks and other human health effects.

Authors:  H Becher; D Flesch-Janys
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

2.  Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.

Authors:  D Jung; P A Berg; L Edler; W Ehrenthal; D Fenner; D Flesch-Janys; C Huber; R Klein; C Koitka; G Lucier; A Manz; A Muttray; L Needham; O Päpke; M Pietsch; C Portier; D Patterson; W Prellwitz; D M Rose; A Thews; J Konietzko
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

3.  Immunologic biomarkers in relation to exposure markers of PCBs and dioxins in Flemish adolescents (Belgium).

Authors:  Rosette L Van Den Heuvel; Gudrun Koppen; Jan A Staessen; Elly Den Hond; Geert Verheyen; Tim S Nawrot; Harry A Roels; Robert Vlietinck; Greet E R Schoeters
Journal:  Environ Health Perspect       Date:  2002-06       Impact factor: 9.031

4.  Prenatal exposure to TCDD and atopic conditions in the Seveso second generation: a prospective cohort study.

Authors:  Morgan Ye; Marcella Warner; Paolo Mocarelli; Paolo Brambilla; Brenda Eskenazi
Journal:  Environ Health       Date:  2018-02-27       Impact factor: 5.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.